Pathogenicity of Lloviu and Bombali Viruses in Type I Interferon Receptor Knockout Mice

J Infect Dis. 2023 Nov 13;228(Suppl 7):S548-S553. doi: 10.1093/infdis/jiad226.

Abstract

Type I interferon receptor knockout (IFNAR-/-) mice are not able to generate a complete innate immune response; therefore, these mice are often considered to assess the pathogenicity of emerging viruses. We infected IFNAR-/- mice with a low or high dose of Lloviu virus (LLOV) or Bombali virus (BOMV) by the intranasal (IN) or intraperitoneal (IP) route and compared virus loads at early and late time points after infection. No signs of disease and no viral RNA were detected after IN infection regardless of LLOV dose. In contrast, IP infections resulted in increased viral loads in the high-dose LLOV and BOMV groups at the early time point. The low-dose LLOV and BOMV groups achieved higher viral loads at the late time point. However, there was 100% survival in all groups and no signs of disease. In conclusion, our results indicate a limited value of the IFNAR-/- mouse model for investigation of the pathogenicity of LLOV and BOMV.

Keywords: Cuevavirus; Ebolavirus; emerging filovirus; intranasal infection; intraperitoneal infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Ebolavirus* / genetics
  • Immunity, Innate
  • Interferon Type I*
  • Mice
  • Mice, Knockout
  • Receptor, Interferon alpha-beta / genetics
  • Virulence

Substances

  • Receptor, Interferon alpha-beta
  • Interferon Type I